Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06705205 · ClinicalTrials.gov registry record · NA
Short, Animated Storytelling (SAS) for Addiction Stigma Reduction
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 13,397
- Enrollment target
NCT06705205: Completed NA study, sponsored by Stanford University.
NCT06705205 is a NA study that has completed, run by Stanford University. The registered enrollment target is 13,397 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (855% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06705205, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13,397 participants
- Enrollment target
Study Summary
Stigma towards people with addiction is a well-documented problem that negatively impacts help-seeking, treatment and recovery. Social contact with people recovering from addiction can promote empathy and reduce stigma, but social contact is difficult to scale. Short, animated storytelling (SAS) is a novel health communication approach that scales easily because it can leapfrog barriers associated with language, culture, literacy and education levels. This study will investigate if a SAS video intervention can be used to reduce stigma, boost optimism and hope, and increasing empathy towards people with addiction. The study will also explore mechanisms of action of SAS interventions, by measuring the contribution of sound design to the effect of the intervention.
Primary Outcome
Participants complete an 18-item shortened version of the validated AQ. The AQ-18 will be scored along a 9-point Likert scale indicating the extent to which participants agree with the item ranging from "not at all" to "very much" with a maximum score of 27 for each 3-item construct. Higher scores indicate greater stigma.
Interventions
- OTHER SAS video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,397 participants |
| Start Date | 2025-07-03 |
| Est. Completion | 2025-08-22 |
| Phase | NA |
What the finished NCT06705205 record still lists
NCT06705205 is an interventional study that assigns participants to a tested intervention. Its 13,397 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (855% higher).
The record links to 0 conditions, and to 1 intervention - of which SAS video is the first listed.
NCT06705205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06705205 about?
NCT06705205 is a clinical study titled "Short, Animated Storytelling (SAS) for Addiction Stigma Reduction". Stigma towards people with addiction is a well-documented problem that negatively impacts help-seeking, treatment and recovery. Social contact with people recovering from addiction can promote empathy and reduce stigma, but social contact is difficult to scale. Short, animated storytelling (SAS) is ...
What is the current status of trial NCT06705205?
This trial is currently completed. It is a NA study. The enrollment target is 13,397 participants. The study started on 2025-07-03. Estimated completion is 2025-08-22.
What interventions are being tested in trial NCT06705205?
The interventions under investigation include: SAS video (OTHER).
Who is sponsoring clinical trial NCT06705205?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06705205's enrollment target sits among peer trials
13,397 13th of 2000 higher than 1,988 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI